Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
557795-19-4
Purity
95%
Sunitinib is a small-molecule multi-targeted receptor tyrosine kinase inhibitor. It is used as the treatment of advanced renal cell carcinoma as well as the treatment of gastrointestinal stromal tumor after disease progression on or intolerance to imatinib mesylate.
Properties
Name
Sunitinib
Smiles
CCN(CC)CCNC(=O)C1=C(C)NC(/C=C/2\C(=O)NC=3C=CC(F)=CC23)=C1C
Targets
Please log in to see this information
SDS
Su11248 | sunitinib | sunitnib | sutent
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$38
2 mg
$40
5 mg
$42
10 mg
$44
15 mg
$46
20 mg
$49
25 mg
$54
30 mg
$57
35 mg
$60
40 mg
$62
45 mg
$65
50 mg
$67
75 mg
$70
100 mg
$POA
Quantity
1
Total amount
$ 42
Su11248 | sunitinib | sunitnib | sutent
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.
CAS:341031-54-7
0